Embecta Corp. (EMBC)
5.18
-0.37
(-6.67%)
USD |
NASDAQ |
Sep 09, 13:06
Embecta Total Liabilities (Quarterly) : 1.878B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.878B |
| March 31, 2026 | 1.655B |
| December 31, 2025 | 1.677B |
| September 30, 2025 | 1.768B |
| June 30, 2025 | 1.827B |
| March 31, 2025 | 1.856B |
| December 31, 2024 | 1.918B |
| September 30, 2024 | 2.024B |
| June 30, 2024 | 2.031B |
| March 31, 2024 | 1.969B |
| Date | Value |
|---|---|
| December 31, 2023 | 2.011B |
| September 30, 2023 | 2.036B |
| June 30, 2023 | 2.062B |
| March 31, 2023 | 2.033B |
| December 31, 2022 | 2.033B |
| September 30, 2022 | 1.978B |
| June 30, 2022 | 1.897B |
| March 31, 2022 | 1.801B |
| December 31, 2021 | 189.40M |
| September 30, 2021 | 194.00M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Artivion, Inc. | 626.35M |
| Abbott Laboratories | 57.45B |
| AngioDynamics, Inc. | 96.34M |
| Alphatec Holdings, Inc. | 779.49M |
| AtriCure, Inc. | 160.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.265B |
| Shareholders Equity (Quarterly) | -612.70M |
| Debt to Equity Ratio | -2.451 |
| Current Ratio | 1.680 |
| Net Debt Paydown Yield | 7.24% |